首页> 美国卫生研究院文献>Molecular Therapy. Nucleic Acids >Strong Immune Responses Induced by Direct Local Injections of Modified mRNA-Lipid Nanocomplexes
【2h】

Strong Immune Responses Induced by Direct Local Injections of Modified mRNA-Lipid Nanocomplexes

机译:直接局部注射修饰的mRNA-脂质纳米复合物诱导的强免疫反应。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

transcribed mRNAs hold the promises of many medical applications in disease prevention and treatment, such as replacement or supplement of missing or inadequately expressed endogenous proteins and as preventive vaccines against infectious diseases, therapeutic vaccines, or other protein-based biopharmaceutics for cancer therapy. A safe and efficient delivery system for mRNA is crucial to the success of mRNA therapeutic applications. In this study, we report that InstantFECT, a liposome-based transfection reagent, can pack pseudouridine-incorporated mRNA into nanocomplexes that are highly efficient in mediating transfection in multiple organs after local delivery. High levels of expression of EGFP and luciferase reporters after intratumoral and intramuscular injections were observed, which lasted for up to 96 hrs. Immunogenicity of antigens encoded by mRNA delivered with nanocomplex was investigated by subcutaneous delivery of modified mRNAs encoding adenosine synthase A (AdsA) and a model tumor-associated antigen ovalbumin (OVA). Strong T cell responses were provoked by both mRNAs delivered. Therapeutic and protective treatment with the OVA mRNA-liposome nanocomplex significantly inhibited B16-OVA tumor progression and increased mouse survival. There was no sign of obvious toxicity related to the treatment both in tissue culture and in mice. An intravenous injection of the same dosage of the modified mRNA-lipid nanocomplex showed minimal transfection in major organs, indicating an excellent safety feature as the gene transfer occurred only at the injection sites, whereas intravenous (i.v.) injection with the same amount of mRNA complexed with a commercial transfection reagent Trans-IT showed luciferase expression in the spleen. In summary, InstantFECT cationic liposomes provide a safe and efficient locoregional delivery of mRNA and could be a useful tool for basic research and for the development of mRNA-based therapies.
机译:转录的mRNA在疾病预防和治疗中具有许多医学应用的前景,例如替换或补充缺失或表达不足的内源蛋白质,以及作为针对传染病的预防性疫苗,治疗性疫苗或其他基于蛋白质的生物药物用于癌症治疗。安全有效的mRNA递送系统对于mRNA治疗应用的成功至关重要。在这项研究中,我们报道InstantFECT,一种基于脂质体的转染试剂,可以将掺入假尿苷的mRNA包装到纳米复合物中,这些纳米复合物在局部递送后能有效介导多个器官的转染。在瘤内和肌内注射后,观察到EGFP和荧光素酶报告基因的高水平表达,持续了长达96小时。通过皮下递送编码腺苷合酶A(AdsA)和模型肿瘤相关抗原卵清蛋白(OVA)的修饰mRNA,研究了纳米复合物递送的mRNA编码的抗原的免疫原性。传递的两种mRNA均引起强烈的T细胞反应。用OVA mRNA-脂质体纳米复合物进行治疗和保护性治疗可显着抑制B16-OVA肿瘤进展并增加小鼠存活率。在组织培养和小鼠中都没有与该治疗有关的明显毒性迹象。相同剂量的修饰的mRNA-脂质纳米复合物的静脉内注射显示主要器官的转染极少,这表明其出色的安全性,因为仅在注射部位发生了基因转移,而静脉内(iv)注射了相同量的复合mRNA用商业转染试剂Trans-IT可以显示萤光素酶在脾脏中的表达。总之,InstantFECT阳离子脂质体可提供安全有效的mRNA局部区域递送,并且可能是基础研究和基于mRNA的疗法开发的有用工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号